PRR.AX - PRIMA FPO

ASX - ASX Delayed Price. Currency in AUD
0.025
0.000 (0.000%)
At close: 2:30PM AEDT
Stock chart is not supported by your current browser
Previous Close0.025
Open0.025
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.024 - 0.025
52 Week Range0.024 - 0.025
Volume961,828
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE4 months ago

    Edison Issues ADR Update On Immutep (IMMP)

    LONDON, UK / ACCESSWIRE / December 12, 2017 / Prima BioMed has changed its name to Immutep Limited (NASDAQ: PBMD) following shareholder approval in November. It reported an encouraging 33% preliminary ...

  • ACCESSWIRE7 months ago

    Edison Issues ADR Update On Prima Biomed (PBMD)

    LONDON, UK / ACCESSWIRE / October 2, 2017 / Data presented at the European Society for Medical Oncology (ESMO) Congress by third parties has positive implications for Prima Biomed's (NASDAQ: PBMD) LAG3 ...

  • Prima Biomed's Intra-Tumor Study on Lead Candidate Approved
    Zacks9 months ago

    Prima Biomed's Intra-Tumor Study on Lead Candidate Approved

    Prima Biomed Ltd. (PBMD) announced that a new clinical study, INSIGHT, on its lead candidate IMP321 has received regulatory approval for initiation